Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Interest & Investment Income: 2010-2014

Historic Interest & Investment Income for Catalyst Pharmaceuticals (CPRX) over the last 4 years, with Sep 2014 value amounting to $5,924.

  • Catalyst Pharmaceuticals' Interest & Investment Income fell 42.59% to $5,924 in Q3 2014 from the same period last year, while for Sep 2014 it was $76,538, marking a year-over-year increase of 119.55%. This contributed to the annual value of $47,421 for FY2013, which is 216.65% up from last year.
  • According to the latest figures from Q3 2014, Catalyst Pharmaceuticals' Interest & Investment Income is $5,924, which was down 62.37% from $15,744 recorded in Q2 2014.
  • Over the past 5 years, Catalyst Pharmaceuticals' Interest & Investment Income peaked at $32,760 during Q1 2014, and registered a low of $1,317 during Q1 2012.
  • For the 3-year period, Catalyst Pharmaceuticals' Interest & Investment Income averaged around $10,620, with its median value being $8,526 (2013).
  • As far as peak fluctuations go, Catalyst Pharmaceuticals' Interest & Investment Income tumbled by 58.79% in 2012, and later surged by 524.62% in 2013.
  • Quarterly analysis of 5 years shows Catalyst Pharmaceuticals' Interest & Investment Income stood at $3,418 in 2010, then declined by 29.26% to $3,169 in 2011, then fell by 13.41% to $9,550 in 2012, then skyrocketed by 131.52% to $22,110 in 2013, then plummeted by 42.59% to $5,924 in 2014.
  • Its Interest & Investment Income was $5,924 in Q3 2014, compared to $15,744 in Q2 2014 and $32,760 in Q1 2014.